Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease
NCT02443779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2019-04-12
Summary
The purpose of this study is to examine if a correlation exists between findings from brain imaging studies of the status of the dopamine system in the brain using DaTscan and SPECT imaging, clinical symptoms of Parkinson's disease, and changes in the structure of the retina as detected by optical coherence tomography (OCT) in recently diagnosed and more advanced Parkinson's disease patients.
Conditions
Sponsors & Collaborators
-
Wills Eye Hospital
collaborator UNKNOWN -
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Jay S Schneider, PhD · Thomas Jefferson University
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- United States
Study Locations
More Related Trials
-
Assessment of Pupil Light Responses in Patients With Parkinson Disease
NCT04117555 ·Status: RECRUITING
-
Non-invasive Diagnosis of Parkinson's Disease
NCT07201610 ·Status: NOT_YET_RECRUITING
-
Non-motor Symptoms and Brain Dopamine Transporter Binding
NCT02650843 ·Status: ACTIVE_NOT_RECRUITING
-
Quantification of Beta Activity in Routine EEG Recordings in Parkinson's Disease Patients
NCT03103347 ·Status: COMPLETED
-
Neuroimaging Studies of Depression in Parkinson's Disease
NCT00518258 ·Status: COMPLETED
-
Compensation Mechanisms in Parkinson's Disease
NCT02869945 ·Status: COMPLETED ·Phase: NA
-
Cerebral Contributions to Symptom Progression in PD
NCT05169827 ·Status: COMPLETED
-
Psychological Effects of Levodopa in Parkinson's Disease
NCT05119075 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
NCT07244640 ·Status: RECRUITING
-
Imaging Studies of Cognitive Impairment in Parkinson s Disease
NCT01862744 ·Status: COMPLETED
-
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
NCT01089270 ·Status: UNKNOWN
-
Imaging Biomarkers in Parkinson s Disease
NCT01496599 ·Status: COMPLETED
-
Study of Eye Movements (EYE) as Early Markers of Brain Dysfunction (BRAIN) in Parkinson's Disease (PARK)
NCT04212637 ·Status: UNKNOWN ·Phase: NA
-
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622 ·Status: COMPLETED
-
Video-oculography and Parkinson's Disease
NCT04731246 ·Status: RECRUITING ·Phase: NA
-
Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty
NCT00129675 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
NCT05862649 ·Status: COMPLETED ·Phase: NA
-
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473 ·Status: COMPLETED
-
Study on the Visual Condition in Parkinson's Disease
NCT03743467 ·Status: UNKNOWN
-
Visuomotor Control in Parkinson Disease
NCT06918938 ·Status: RECRUITING
-
Prevalence of Visual Dysfunction in Neurological Disorders
NCT04836715 ·Status: COMPLETED
-
Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease
NCT00736671 ·Status: COMPLETED
-
PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease
NCT02801110 ·Status: UNKNOWN
-
Neuroplasticity in Parkinson's Disease
NCT05286736 ·Status: RECRUITING
-
A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients
NCT05795023 ·Status: COMPLETED ·Phase: NA